Portal Biotechnologies, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Portal Biotechnologies, Inc. - overview

Established

2023

Location

Watertown, MA, US

Primary Industry

Biotechnology

About

Based in Massachusetts, US, and founded in 2023 by CEO Armon Sharei, Portal Biotechnologies specialises in developing advanced platforms that facilitate the efficient delivery of various cargoes into a diverse range of cell types, including but not limited to T cells, B cells, NK cells, and iPSCs. In December 2024, Portal Biotechnologies, Inc. raised USD 7 million in seed funding led by new investor IA Ventures, with participation from returning investor Pear VC. New investors IKJ Capital, PageOne.


vc, Undeterred Capital, and other unspecified investors also participated in the round. Portal's flagship product, The Gateway, offers performance in boosting cell function compatibility across a diverse range of cell types and cargoes, including mRNA, siRNA, proteins, CRISPR RNPs, small molecules, and more. Their proprietary membrane is optimised for delivery, cell viability, and flexible buffer compatibility. Additionally, the product is future-proof, with a subscription model that includes free hardware upgrades to future models.


Portal's partner network includes various entities in the life sciences field, such as biotech companies, pharmaceutical companies, academic institutions, and cell therapy manufacturers. The company plans to use the December 2024 funding to introduce its next-generation products and foster sustained growth.


Current Investors

Pear VC, 10X Capital, Conscience VC

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy

Website

www.portal.bio

Verticals

E-commerce

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.